Clinical trials
Infusion clinical trials
Below are recruiting infusion clinical trials, each written for real people, not researchers. We’re tracking 504 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06785987Enrolling by invitationPhase 4
Lidocaine Drip During Thyroid Surgery with Nerve Monitoring
This study tests whether giving a continuous lidocaine drip during open thyroid surgery can improve pain control and recovery. Lidocaine is a numbing medicine, and researchers want to see if it helps without interfering with the nerve monitor used during surgery.
Kaohsiung, TaiwanAges 20–75 - NCT07163299Enrolling by invitationPhase 1/Phase 2
Cooling artery treatment with magnesium for stroke clot removal
This trial tests adding a cooled magnesium solution directly into the brain artery during standard clot removal to see if it helps limit brain damage and improve recovery. The magnesium and cooling aim to protect brain tissue while the clot is being taken out.
Xuzhou, JiangsuAges 18–80 - NCT06427707RecruitingPhase 2/Phase 3
Adding propofol or ketamine to magnesium and lidocaine for nasal surgery
This trial tests whether adding propofol or ketamine to a standard combination of magnesium and lidocaine improves pain control and recovery for people having nasal surgery. It aims to find a better way to manage anesthesia and reduce side effects.
Cairo, Cairo GovernorateAges 18–60 - NCT03581370RecruitingPhase 3
Short vs longer infusion antibiotic for ventilator lung infection
This Phase 3 study compares a shorter vs longer drip schedule of the antibiotic ceftolozane-tazobactam in ICU patients with a specific type of ventilator-associated pneumonia caused by Pseudomonas. It aims to find which infusion time works as well (or better) while treating the infection safely.
ToulouseAges 18 years+ - NCT04130464RecruitingPhase 4
Analgesic placed inside the belly for after-surgery pain
This study tests whether placing a pain medicine inside the abdomen during hysterectomy can reduce postoperative pain. It targets people having specific types of minimally invasive hysterectomy for non-cancer reasons.
Washington D.C., District of ColumbiaAges 18–65 - NCT07361822Recruiting
Opioid use after surgery: standard vs smart pump
This trial compares two ways to give pain medicine through an IV pump after surgery. It tests if a smart pump that adjusts the dose based on feedback works better than a standard pump that delivers a steady, fixed dose. This might help patients use less opioid pain medicine.
BeijingAges 18–65 - NCT07375121Recruiting
Comparing two pain pump settings for mixed surgeries
This study compares two ways of delivering pain medicine through an IV pump (called PCA) after surgery. One method gives a steady dose, and the other slowly reduces the dose. The goal is to see which works better and has fewer side effects.
BeijingAges 18–65 - NCT06752863RecruitingPhase 4
Study of two drugs for controlled low blood pressure during surgery
This trial compares two medications, labetalol and dexmedetomidine, given as infusions to lower blood pressure during ear, nose, and throat surgeries. The goal is to find which drug works better and safer for patients.
Cairo, Cairo GovernorateAges 20–50 - NCT07239375Recruiting
Bone Marrow Infusion for Blood Cancer Patients in Critical Care
This trial studies a way to give fluids and medicines directly into the bone marrow (intraosseous infusion) for people with serious blood diseases who are in critical condition. It may help when regular IV access is difficult or urgent.
Taiyuan, ShanxiAges 18–65 - NCT07183592Recruiting
Changing IV tubing in the ICU: does less often harm?
This trial compares changing the tubing attached to central lines every 4 days versus every 7 days, to see if less frequent changes cause more infections. If you have a central line in the ICU that will stay in for at least a week, this study may help decide the safest schedule.
Saint-Pierre, La RéunionAges 18 years+ - NCT03533816RecruitingPhase 1
Gamma delta T-cell infusion after stem cell transplant
This early-phase study tests giving a special immune-cell treatment after an allogeneic (donor) stem cell transplant, plus a medication given after transplant to help the new immune system work better. It may help prevent or treat cancer returning after transplant.
Westwood, KansasAges 18–65 - NCT04332874RecruitingPhase 2
Pembrolizumab with local limb chemotherapy for sarcoma in arms or legs
This trial tests whether giving pembrolizumab along with chemotherapy delivered directly into an arm or leg (isolated limb infusion) can shrink sarcoma tumors. It is for people with advanced or metastatic sarcoma in an arm or leg who can safely have this local treatment.
Basking Ridge, New JerseyAges 12 years+ - NCT05681442RecruitingPhase 4
Antibiotics given in different ways for hospital sepsis
This study tests whether giving certain antibiotics intermittently versus continuously, along with a second antibiotic, works better for hospital-acquired sepsis. It may help doctors choose the most effective way to control serious infections.
AmiensAges 18 years+ - NCT06248593RecruitingPhase 4
Continuous Norepinephrine vs Phenylephrine for Cesarean Blood Pressure
This study compares two medicines (norepinephrine and phenylephrine) given continuously through a vein to keep your blood pressure stable during a planned cesarean with spinal anesthesia. It aims to see which medicine works better for you and your baby.
FesAges 18–45 - NCT06483737Recruiting
Albumin for cirrhosis patients with hepatic encephalopathy
This trial tests whether giving human albumin through a vein can help people with liver cirrhosis who have confusion or drowsiness from a condition called hepatic encephalopathy. It is for patients with low albumin levels.
Shenyang, LiaoningAges 18 years+ - NCT06532461Recruiting
Comparing 3 vs 7 day insulin pump wear in teens with type 1 diabetes
This study tests if wearing an insulin pump set for 7 days is as safe and effective as changing it every 3 days. It is for children and teens with type 1 diabetes who already use the Medtronic 780G system.
Herlev, CapitalAges 7–18 - NCT03916978RecruitingPhase 2/Phase 3
PRP treatment to help restore ovarian function in menopause
This trial tests whether injecting your own PRP (platelet-rich plasma) into the ovaries can improve ovarian function in some menopausal women. It may help those whose menopause seems less advanced, but not everyone will be eligible based on health and test results.
AthensAges 45–55 - NCT03951194RecruitingPhase 2/Phase 3
Platelet-rich plasma infusion for perimenopausal women
This trial tests whether infusing a concentration of your own blood platelets into the ovary can help regulate menstrual cycles and improve ovarian function in women going through perimenopause.
AthensAges 40–50 - NCT06857773RecruitingPhase 3
Combined pump therapy and chemo for liver-only colorectal cancer
This trial tests a treatment approach where you receive chemotherapy directly into your liver through a surgically placed pump, combined with standard systemic chemotherapy (given through a vein). The goal is to shrink liver tumors enough so they can be removed later with surgery. It is for people whose colorectal cancer has spread only to the liver and has not been treated before.
AmsterdamAges 18 years+ - NCT06972537Recruiting
Piperacillin-Tazobactam Dosing for Pneumonia in Older Adults
This study looks at the best way to give the antibiotic piperacillin-tazobactam (Zosyn) to people 65 and older who have pneumonia. It aims to make treatment more effective and safer for older adults.
Jinan, ShandongAges 65–100 - NCT07119463RecruitingPhase 2
Albumin infusion to reduce complications after gastric cancer surgery
This trial tests whether giving albumin (a protein in the blood) during and after surgery can help prevent complications in people with stomach cancer. It is for those who have surgery to remove their tumor and have normal or near-normal blood albumin levels before surgery.
Changchun, JilinAges 18–80 - NCT07369024RecruitingPhase 2
Study of low-dose ketamine for sickle cell pain crisis
This study tests whether a low-dose of ketamine (a pain medicine) can help children and young adults with sickle cell disease who are in a pain crisis. It aims to provide better pain relief while avoiding some side effects of standard painkillers.
Torrance, CaliforniaAges 5–20 - NCT07377695Recruiting
Remimazolam dosing: computer-controlled vs. manual
This trial compares two ways of giving the sedative remimazolam during brain bypass surgery. It looks at which method uses less medicine. If you are having this surgery, you may be able to join.
Seongnam-si, Gyeonggi-doAges 19 years+ - NCT07423650RecruitingPhase 4
Continuous Nefopam infusion after pancreas surgery
This trial tests if giving a steady dose of a painkiller called nefopam through an IV can help manage pain after a Whipple procedure (pancreatoduodenectomy). It aims to see if this approach reduces the need for other pain medications and improves recovery.
Cluj-Napoca, ClujAges 18–80
Hear when a new Infusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infusion?
- Yes. Clin2 currently lists 504 recruiting infusion studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infusion trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infusion trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.